Quantcast

Garden State Times

Wednesday, April 23, 2025

FDA conducted lowest number of inspections on Biologics companies in New Jersey during March

Webp btx5fmm7r5ptppa0ig00pmlbqqx5

Vid Desai FDA’s Chief Information Officer | Official Website

Vid Desai FDA’s Chief Information Officer | Official Website

In March, one Biologics company received an FDA inspection in New Jersey, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in New Jersey, equalling 5.9% of all inspections in March.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in New Jersey During March
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Drug Quality Assurance1
Food Composition, Standards, Labeling and Econ4
Foodborne Biological Hazards114
Human Cellular, Tissue, and Gene Therapies1

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS